Regarding full details of the resolutions, referral is made to the notice convening the AGM and the complete proposals. The notice convening the AGM and the complete proposals are available at the company's website, www.concentricab.com.
Adoption of the income statements and the balance sheets
The general meeting resolved to adopt the income statement and balance sheet and the consolidated income statement and consolidated balance sheet for the financial year 2023.
Dividend
The general meeting resolved, in accordance with the board's proposal, on a dividend of
Discharge from liability
The general meeting discharged each who had held the position as CEO or board member from personal liability during the financial year 2023.
Board and auditors
The general meeting re-elected
The registered accounting firm
The general meeting resolved that the chair of the board will receive
The general meeting resolved that fees will be paid to the auditor according to approved current account.
Instructions for the nomination committee
The general meeting resolved, in accordance with the nomination committee's proposal, on instructions for the nomination committee. The proposal is available in full in the notice for the general meeting. The main change consists of the chair of the board becoming an adjunct member of the nomination committee, instead of an ordinary member.
Approval of remuneration report
The general meeting resolved, in accordance with the board's proposal, to approve the board's remuneration report on remuneration to the CEO in accordance with Chapter 8, Section 53 a of the Swedish Companies Act.
Performance based incentive programme (LTI 2024)
In accordance with the board's proposal, the general meeting resolved to implement a long-term performance based incentive programme, LTI 2024. The programme is offered to up to 11 senior executives, including the CEO, and 25 other key employees (total of 37 employees), who are offered, free of charge, to receive a performance share award entitling the participant to receive an allocation of a number of Concentric shares free of charge, subject to the satisfaction of certain performance conditions. Any performance shares will be allocated after the expiration of the three-year vesting period, which begins on the date decided by Concentric and notified to the participant in LTI 2024 and continues until the day of publication of the interim report for Q1 of the 2027 financial year.
The LTI 2024 may result in annual costs of no more than MSEK 8.5 for Concentric if the performance criteria are fully met, and an annual share price growth of 15 per cent is assumed. In addition to this, social security charges will apply in the year of vesting, 2027. Social security charges may amount to no more than MSEK 1.8 annually, based on the same assumptions.
Issue of warrants and approval of transfer of warrants
As one of several options to secure a cost-efficient supply of Concentric shares for transfer under the LTI 2024, the general meeting adopted the board's proposal to issue, free of charge, 154,260 warrants to its wholly-owned subsidiary Concentric Skånes
Furthermore, the general meeting resolved to approve that Concentric Skånes
Acquisitions and transfers of own shares
In accordance with the board's proposal, the general meeting resolved to authorise the board to acquire and/or transfer own shares, which in the latter case may be resolved on with deviation from the shareholders' preferential rights, on one or more occasions until the annual general meeting 2025.
Acquisition of the company's own shares shall be made on Nasdaq Stockholm, for the purpose of being able to improve the company's capital structure and to enable share transfers in accordance with the authorisation for the board to transfer own shares and resolution on transfer of own shares to participants in LTI 2021-2024, to increase the flexibility for the board in connection to potential future corporate acquisitions, as well as to cover costs for LTI 2021-2024 and enable delivery of shares in accordance with LTI 2021-2024. The company's total holdings of own shares must not at any time exceed 10 per cent of the total number of shares in the company.
Transfer of the company's own shares may be done for the purpose of being able to improve the company's capital structure, to cover costs relating to LTI 2021-2024 (including costs related to the JSOP) as well as to increase the flexibility of the board in connection to potential future corporate acquisitions, by facilitating a fast and cost-efficient financing by divesting holdings of own shares. Transfer of own shares can be made either on Nasdaq Stockholm or in another manner, and the maximum number of shares that may be transferred is the total number of own shares held by the company at the time of the board's resolution to transfer the shares.
In accordance with the board's proposal, the general meeting also approved transfers of own shares to participants in the LTI 2024 on the terms and conditions that apply for the incentive programme.
For additional information please contact
https://news.cision.com/concentric-ab/r/report-from-concentric-ab-s-annual-general-meeting-on-april-18--2024,c3961277
https://mb.cision.com/Main/1643/3961277/2730275.pdf
(c) 2024 Cision. All rights reserved., source